Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia
View ORCID ProfileKarianne Svendsen, View ORCID ProfileJacob Juel Christensen, Jannicke Igland, Henriette Walaas Krogh, Liv J. Mundal, View ORCID ProfileDavid R. Jacobs Jr., View ORCID ProfileMartin P. Bogsrud, Kirsten B. Holven, View ORCID ProfileKjetil Retterstøl
doi: https://doi.org/10.1101/2024.09.03.24312275
Karianne Svendsen
1Lipid Clinic, Oslo University Hospital, Oslo, Norway
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
3Cancer Registry of Norway, Norwegian Institute of Public Health, 0379 Oslo, Norway
Jacob Juel Christensen
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Jannicke Igland
4Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; Department of Health and Social Science, Centre for Evidence-Based Practice, Western Norway
5Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway
Henriette Walaas Krogh
6Department of Non-Communicable Diseases, Division of Prevention and Public Health, Norwegian Directorate of Health, Oslo, Norway
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Liv J. Mundal
1Lipid Clinic, Oslo University Hospital, Oslo, Norway
David R. Jacobs Jr.
7University of Minnesota, Minneapolis, Minnesota, USA
Martin P. Bogsrud
8Unit for Cardiac and Cardiovascular Genetics, Oslo University Hospital, Oslo, Norway
Kirsten B. Holven
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
9Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital, Oslo, Norway
Kjetil Retterstøl
1Lipid Clinic, Oslo University Hospital, Oslo, Norway
2Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Article usage
Posted September 04, 2024.
Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia
Karianne Svendsen, Jacob Juel Christensen, Jannicke Igland, Henriette Walaas Krogh, Liv J. Mundal, David R. Jacobs Jr., Martin P. Bogsrud, Kirsten B. Holven, Kjetil Retterstøl
medRxiv 2024.09.03.24312275; doi: https://doi.org/10.1101/2024.09.03.24312275
Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia
Karianne Svendsen, Jacob Juel Christensen, Jannicke Igland, Henriette Walaas Krogh, Liv J. Mundal, David R. Jacobs Jr., Martin P. Bogsrud, Kirsten B. Holven, Kjetil Retterstøl
medRxiv 2024.09.03.24312275; doi: https://doi.org/10.1101/2024.09.03.24312275
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)